Showing results (71-80 of 192) with videos related to

Sort By:
Pageof 20
Rheumatology (Oxford, England)|June 1, 2022
Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLESahwa Elbagir, Lina-Marcela Diaz-Gallo, Giorgia Grosso, et al.
Molecular Medicine (Cambridge, Mass.)|September 17, 2010
High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestationsAnnette Bruchfeld, Mårten Wendt, Johan Bratt, et al.
Rheumatology (Oxford, England)|February 25, 2026
CD72 downregulation on DN2 B cells associates with disease activity and resistance to rituximab in systemic lupus erythematosusKittikorn Wangriatisak, Wenqi Huang, Giorgio Sechi, et al.
Rheumatology Advances in Practice|November 20, 2020
Venous thromboembolism in anti-neutrophil cytoplasmic antibody-associated vasculitis: an underlying prothrombotic condition?Aleksandra Antovic, Einar Svensson, Björn Lövström, et al.
Frontiers in Pharmacology|May 22, 2020
Anti-Inflammatory Properties of Chemical Probes in Human Whole Blood: Focus on Prostaglandin E<sub>2</sub> ProductionFilip Bergqvist, Yvonne Sundström, Ming-Mei Shang, et al.
Arthritis Care & Research|July 29, 2018
The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus ErythematosusIoannis Parodis, Angie H Lopez Benavides, Agneta Zickert, et al.
Frontiers in Immunology|February 12, 2019
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic UseKerstin Sandholm, Barbro Persson, Lillemor Skattum, et al.
Scientific Reports|October 26, 2016
Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associationsFariborz Mobarrez, Anna Vikerfors, Johanna T Gustafsson, et al.
Pageof 20